As a publicly traded company, it has never turned a profit, and side ventures to expand its business into health care and the biotech industries failed. In September, all seven of 23andMe's ...

You can reach Jason on Signal at JasonMast.05. Prime Medicine, a biotech whose wild ambitions for a powerful gene editing technology sank as the biotech market slumped, announced Monday it is ...

GUERNSEY - RTW Biotech Opportunities Ltd has announced that its Annual General Meeting (AGM) is set to take place on June 9, 2025, at 2pm BST in St Peter Port, Guernsey. This gathering will allow ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Ajooni Biotech Limited was originally incorporated as a Private Limited Company with the name Ajooni Biotech Private Limited at Chandigarh on 17th February, 2010. Consequent upon conversion of the ...

Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001. The Company convertedfrom a Private Limited Company to a Public Limited Company and the name ...

Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III ...

SINGAPORE - Singapore biotech firm Mirxes launched its initial public offering (IPO) in Hong Kong on May 15, aiming to raise HK$1.09 billion (S$181 million) to support stronger growth in the ...

Hyderabad: Bharat Biotech International Ltd on Wednesday said its oral Cholera Vaccine Hillchol has successfully completed phase III clinical trials. The vaccine maker, in a press release, said it has ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Intellia Therapeutics has said it will reduce its headcount by 27% this year and shelve early-stage R&D programmes as it puts its resources behind two priority drug candidates. The specialist in ...

The trend has been historically high with biotech start-ups and is growing rapidly with digital health start-ups in US, Europe, and Asia. Although these deals are increasingly commonplace (and for ...